Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients

Philip Garrity, Alicia Danforth, Brian Anderson, Jason M. Thompson

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (50)

  1. A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers. 2025-09-01 · Expand citations
  2. Increased global integration in the brain after psilocybin therapy for depression. 2022-04-01 · Expand citations
  3. Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence. 2021-09-01 · Expand citations
  4. Potential Therapeutic Effects of Psilocybin. 2017-07-01 · Expand citations
  5. Developing Guidelines and Competencies for the Training of Psychedelic Therapists 2017-06-29 · Expand citations
  6. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  7. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  8. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
  9. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  10. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  11. OpenAlex W173089895
  12. OpenAlex W1978032191
  13. OpenAlex W1989881423
  14. OpenAlex W2000720463
  15. OpenAlex W2009478966
  16. OpenAlex W2053764826
  17. OpenAlex W2063166841
  18. OpenAlex W2088233931
  19. OpenAlex W2113099805
  20. OpenAlex W2113881137
  21. OpenAlex W2118158985
  22. OpenAlex W2120051206
  23. OpenAlex W2134667120
  24. OpenAlex W2166934228
  25. OpenAlex W2552814605
  26. OpenAlex W2610144880
  27. OpenAlex W2625982844
  28. OpenAlex W2803238382
  29. OpenAlex W2809775049
  30. OpenAlex W2889699231
  31. OpenAlex W2890770862
  32. OpenAlex W2906933919
  33. OpenAlex W2908344762
  34. OpenAlex W3006011805
  35. OpenAlex W3049128253
  36. OpenAlex W3085641834
  37. OpenAlex W3181055060
  38. OpenAlex W4200021929
  39. OpenAlex W4220855512
  40. OpenAlex W4220907466
  41. OpenAlex W4285091545
  42. OpenAlex W4378782231
  43. OpenAlex W4386740988
  44. OpenAlex W4389348826
  45. OpenAlex W4390495773
  46. OpenAlex W4392498741
  47. OpenAlex W4410309291
  48. OpenAlex W4410860688
  49. OpenAlex W4412902872
  50. OpenAlex W74705120

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.